text
stringlengths
15
247
Colon, colonoscopic biopsy; Extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma)
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Uterine cervix, punch biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Lung, biopsy; Squamous cell carcinoma
Lung, biopsy; Adenocarcinoma
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 90%
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Rectum, colonoscopic biopsy; Adenocarcinoma, well differentiated
Uterine cervix, punch biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Uterine cervix, punch biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Tubular adenoma with low grade dysplasia
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 3 (Gleason pattern 4: 40%), tumor volume: 90%
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3) with glandular involvement
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Colon, colonoscopic biopsy; Adenocarcinoma, well differentiated
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Uterine cervix, punch biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Chronic nonspecific inflammation
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Colon, colonoscopic biopsy; Chronic nonspecific inflammation
Lung, biopsy; Small cell carcinoma
Lung, biopsy; Small cell carcinoma
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Uterine cervix, colposcopic biopsy; Invasive squamous cell carcinoma
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 40%
Lung, biopsy; Non-small cell carcinoma, favor squamous cell carcinoma
Uterine cervix, punch biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 10%
Lung, biopsy; Adenocarcinoma
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; Endocervical adenocarcinoma, HPV-independent, gastric type
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Colon, colonoscopic biopsy; Tubular adenoma with high grade dysplasia
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, punch biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Colon, colonoscopic biopsy; Adenocarcinoma, well differentiated
Uterine cervix, frozen biopsy; Invasive squamous cell carcinoma
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Lung, biopsy; No evidence of malignancy or granuloma
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Chronic nonspecific inflammation
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3) with glandular involvement
Uterine cervix, punch biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Lung, biopsy; Non-small cell carcinoma, favor squamous cell carcinoma
Lung, biopsy; Fungal infection, morphologically consistent with cryptococcus spp.
Uterine cervix, colposcopic biopsy; Chronic nonspecific cervicitis
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Lung, biopsy; Non-small cell carcinoma, favor adenocarcinoma
Uterine cervix, colposcopic biopsy; Invasive squamous cell carcinoma
Colon, colonoscopic biopsy; Adenocarcinoma, well differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Rectum, colonoscopic biopsy; Tubulovillous adenoma with high grade dysplasia
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; Chronic nonspecific cervicitis
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 90%
Uterine cervix, colposcopic biopsy; Endocervical adenocarcinoma, HPV-associated, usual type
Lung, biopsy; No evidence of malignancy or granuloma
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3) with glandular involvement
Colon, colonoscopic biopsy; Chronic nonspecific inflammation
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3) with glandular involvement
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 2)
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100%
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3)
Uterine cervix, punch biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Rectum, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; High-grade squamous intraepithelial lesion (HSIL; CIN 3) with glandular involvement
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Uterine cervix, colposcopic biopsy; Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30%
Rectum, colonoscopic biopsy; Adenocarcinoma, well differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Prostate, biopsy; Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 60%), tumor volume: 90%
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated
Colon, colonoscopic biopsy; Adenocarcinoma, moderately differentiated